Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

http://www.sys-con.com/node/1421900

Did Jimmy say absorbed already?

Last month, Radient Pharmaceuticals signed a collaboration agreement with PLS whereby, PLS is providing CLIA (Clinical Laboratory Improvement Amendment) certified laboratory support services to RPC, including supporting on-going product development for Onko-Sure and securing insurance reimbursement and CPT code assignments for clinical laboratories using Onko-Sure in commercial laboratory efforts. PLS has also independently validated Onko-Sure as a potential screening tool for breast cancer detection.

Douglas MacLellan, Chairman and CEO of Radient Pharmaceuticals, stated, "Through internal testing we've demonstrated the ability of Onko-Sure to detect a wide range of cancers and are confident this validation study conducted by Provista Life Sciences will demonstrate the utility of our assay as a general cancer screening tool. Given this, RPC's commercialization opportunity of offering Onko-Sure as a low cost general cancer screen, both in the US and globally, is phenomenal."